Skip to main content

Wangzhao Song is Medical Director at Ellogon.AI. In 2016, she moved to the Netherlands to investigate molecular pathology in soft tissue and bone tumors at the University Medical Center of Groningen. In 2020, she achieved her Doctoral degree. As Medical Director, she is responsible for product development and Research & Development of Ellogon.AI from a medical perspective, translating relevant medical developments that add value to the company’s clients. She is working closely with pathology experts to develop the company’s AI solutions. She believes that scientific advances often drive medical science. She is proud to be part of the team. Her professional goal is to provide accurate information to assisting healthcare practitioners in making the right decision by the AI.